The effect of activated vitamin D on reducing the progression from impaired glucose tolerance (IGT) to type 2 diabetes (Phase IV, multicenter, randomized, double blind, placebo controlled, and parallel group comparison)
Phase 4
- Conditions
- Impaired Glucose Tolerance (IGT)
- Registration Number
- JPRN-UMIN000010758
- Lead Sponsor
- Kokura Medical Association Health Testing and Services Center
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 1250
Inclusion Criteria
Not provided
Exclusion Criteria
Participants are ineligible if they meet any of the following criteria: have a history of diabetes; participate in other investigational trials; have a history of taking anti-diabetic drugs, other activated vitamin D, or bisphosphonates within past three months; are pregnant; have coronary, peripheral, or cerebrovascular disease; or have some types of a severe disease (e.g., renal insufficiency, hepatic insufficiency, terminal disease).
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The progression from IGT to type 2 diabetes between the two groups after 3-year treatment.
- Secondary Outcome Measures
Name Time Method